Study of chronic kidney disease-mineral bone disorders in newly detected advanced renal failure patients : a hospital-based cross-sectional study

Abstract EN

We aim to evaluate the disturbances in mineral metabolism, abnormalities in bone mineral density (BMD), and extraskeletal calcification in newly detected, untreated predialysis stage 4 and 5 chronic kidney disease (CKD) patients at a tertiary care hospital in North India.

This is cross-sectional observational study.

A total of 95 (68 males, 27 females) newly detected patients underwent clinical evaluation, biochemical assessment [serum calcium, phosphorus, alkaline phosphatase (ALP), albumin, creatinine, intact parathyroid hormone (iPTH), 25- hydroxyvitamin D (25(OH)D)], BMD measurement (at spine, hip, and forearm) by dual-energy X-ray absorptiometry (DXA), lateral abdominal radiograph [for abdominal aortic calcification (AAC)], skeletal survey (to look for any abnormality including fractures), and echocardiography [for any cardiac valvular calcification (CVC)].

Symptoms related to CKD-mineral bone disorder were seen in 33.6% of the study patients.

Prevalence of hypocalcemia, hyperphosphatemia, hyperparathyroidism, and hypovitaminosis D was 64.2%, 81.1%, 49.5%, and 89.5%, respectively.

CVC was seen in 22.1% of patients on echocardiography, mostly involving the mitral valve.

Patients with CVC were more likely to be males and smokers.

There was no significant difference in iPTH levels between patients with or without CVC.

AAC was seen in 10.5% of patients on lateral abdominal X-ray.

Patients with AAC had higher levels of iPTH, phosphorus, and ALP and lower levels of calcium compared to patients without AAC.

BMD by DXA showed a low bone mass in 41.05% of our patients and was more prevalent in CKD stage 5.

Most of the study patients had hyperparathyroidism and low 25(OH)D levels.

Our study shows that newly detected, naïve Indian CKD patients have a high prevalence of disturbances of mineral metabolism including